Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash & Current Investments: 2020-2024

Historic Cash & Current Investments for MDxHealth (MDXH) over the last 5 years, with Dec 2024 value amounting to $46.8 million.

  • MDxHealth's Cash & Current Investments fell 35.03% to $32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year decrease of 35.03%. This contributed to the annual value of $46.8 million for FY2024, which is 109.12% up from last year.
  • Latest data reveals that MDxHealth reported Cash & Current Investments of $46.8 million as of FY2024, which was up 109.12% from $22.4 million recorded in FY2023.
  • In the past 5 years, MDxHealth's Cash & Current Investments registered a high of $58.5 million during FY2021, and its lowest value of $15.5 million during FY2022.
  • Over the past 3 years, MDxHealth's median Cash & Current Investments value was $34.6 million (recorded in 2023), while the average stood at $35.8 million.
  • In the last 5 years, MDxHealth's Cash & Current Investments soared by 266.69% in 2021 and then tumbled by 73.50% in 2022.
  • Over the past 5 years, MDxHealth's Cash & Current Investments (MRY) stood at $16.0 million in 2020, then skyrocketed by 266.69% to $58.5 million in 2021, then crashed by 73.50% to $15.5 million in 2022, then skyrocketed by 44.36% to $22.4 million in 2023, then soared by 109.12% to $46.8 million in 2024.
  • Its Cash & Current Investments was $46.8 million in FY2024, compared to $22.4 million in FY2023 and $15.5 million in FY2022.